SPECTRA
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency
Solicitation Status: Accepting Submissions – due date varies by technical area. This program has an open funding opportunity. Complete opportunity details and application documents are posted to the System for Award Management (SAM). Stay on this page for an overview of the program. Or, navigate directly to the solicitation posting (ARPA-H-SOL-26-163).
What if everyone on the autism spectrum could be understood and supported as an individual across the lifespan, with precision care that improves health, independence, and quality of life?
The Problem
- Autistic people bring diverse strengths, perspectives, and experiences to their families and communities, while often having widely varying health and support needs. Autism spectrum disorder (ASD) is a complex condition that science has yet to deeply understand, leaving many individuals and families without the support they need to thrive.
- Autistic people experience disproportionately high rates of co-occurring health conditions, including gastrointestinal and sleep disorders, as well as disparities in employment and life expectancy. Too often, individuals and families lack access to the individualized assessment, treatment, and support needed to address these challenges.
- Diagnosis usually comes only after developmental differences are observable, which delays access to care. People diagnosed with ASD also differ substantially in developmental trajectory, co-occurring conditions, environmental exposures, genetic predisposition, and response to treatment—so treatment outcomes vary significantly across individuals.
- Current diagnostic and treatment paradigms rely primarily on costly, time-intensive behavioral observation and one-size-fits-all interventions from specialists with limited availability in much of the country. Research has also not sufficiently explored promising objective, multi-factor measures or the modifiable drivers of health and functional outcomes.
The Solution
- The SPECTRA (Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency) program takes a bold approach, anchoring autism research in objective, multi-factor measurement and computation rather than behavioral observation alone.
- The program is built on the hypothesis that nonlinear interactions among genetic, environmental, family, metabolic, immune, microbiome, and developmental factors shape distinct developmental, health, communication, and functional trajectories.
- By integrating these data across the lifespan, SPECTRA aims to build tools that serve two connected goals: improving quality of life, independence and autonomy for people diagnosed with ASD, and improving assessment so that measurement becomes continuous, real-world, and a natural part of everyday life. Together, these tools will help match individuals to tailored interventions most likely to help and enable continuous improvement of care and outcomes overtime.
Only ARPA-H can...
- Bring together the diverse range of capabilities needed to tackle this challenge, uniting experts across disciplines, institutions, and industry sectors around a common goal.
- Convene stakeholders within scientific fields and across education, pediatrics, and advocacy organizations, and co-design solutions with autistic people and their families so that tools are grounded in lived experience, accessible, and ready for integration in medical, school, home, and community settings.
- De-risk new platforms technologies academia and industry can leverage to develop solutions now and into the future.
Solicitation Overview
Notice ID: ARPA-H-SOL-26-163
To achieve the goals of this program, ARPA-H seeks bold, cross-disciplinary solutions across four technical areas (TAs):
- TA1 - Analysis: Tools to characterize the genetic, environmental, family, metabolic, immune, and developmental factors associated with distinct developmental, health, communication, and functional trajectories. To learn more, download the TA1 & TA2 Overview Briefing (pdf 5.5MG).
- TA2 - Modeling: Federated, privacy-preserving AI platforms that map these trajectories and identify modifiable outcome drivers and actionable targets. To learn more, download the TA1 & TA2 Overview Briefing (pdf 5.5MG).
- TA3 - Precision Intervention: Individualized selection and rigorous testing of interventions to improve outcomes across the lifespan. An Overview Briefing for TA 3 will be available for download around the time the Solutions site opens for submissions.
- TA4 - Enabling Technologies: Accessible tools for communication, quality of life, and embedded assessment that measure real-world function as a byproduct of ordinary use. To learn more, download the TA4 Overview Briefing (pdf 3MB).
Note: Overview Briefings are supplemental resources to the solicitation. You must still access solicitation documents for complete details.
Interested this opportunity? Download the official solicitation documents from SAM.gov. The solicitation documents outline complete opportunity details including requirements, evaluation criteria, eligibility information, and provide application templates with detailed instructions on how to apply.
Ready to apply? To submit, sign-in to the ARPA-H Solutions site. Be sure to check open dates and due dates as they vary by technical area. Reminder, you must first submit a Solution Summary by the date listed in order to qualify for proposal submission.
Key Dates & Deliverables:
1) Solution Summary Due – Varies by technical area
A Solution Summary is required to move forward with this opportunity. After submitting a summary, await feedback from ARPA-H before proceeding.
TA4: October 21, 2026 (3:00PM ET)
This deadline has passed. TA4 is now closed to new submissions.TA1 & TA2: December 2, 2026 (3:00PM ET)
Accepting summary submissions starting November 18, 2026. See solicitation for details.TA3: January 19, 2027 (3:00PM ET)
Accepting summary submissions starting January 4, 2027. Details to be announced in early December.
2) Full Proposal Due – Varies by technical area
Only after having submitted a Solution Summary and receiving feedback from ARPA-H should you proceed with a proposal submission. Encouraged submissions preferred.
- TA4: January 6, 2027 (3:00PM ET)
Accepting proposal submissions starting November 23, 2026 from applicants who met previous deadline requirements. See solicitation for details. - TA1 & TA2: To be announced
Dates and details pending announcement. - TA3: Dates to be announced
Dates and details pending announcement.
Related Links & Resources:
Opportunity-specific FAQs: Review responses to questions from the proposer community.
Application & Submission FAQ: Find answers to common questions about the ARPA-H application process.
Ask A Question (external link): Submit a new question about this opportunity. Sign-in required.
Teaming Directory (external link): ARPA-H encourages proposals from technically diverse teams. To facilitate this process, ARPA-H has created a directory for proposers to share their profiles and learn about other interested parties. Sign-in required.
Submission Resources: Additional resources to help proposers navigate the ARPA-H funding and award process.
Program Manager